Actavis/Forest: roll up, tax down

Actavis/Forest: roll up, tax down

[at Financial Times] – Buy drug company, cut operating costs, cut research spending, pay less tax, watch stock go up. It is a simple plan, and Actavis is sticking to it. The only question is how often the process can be repeated. … more

View todays social media effects on VRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Valeant is hiring next, click here to view

Share this post